CAR-T Cell Therapy for ALL

计划入组 10 人 · 首次发布于 2026 年 7 月 10 日

Allogeneic UCB-derived CAR-T for B-ALL

计划入组 50 人 · 首次发布于 2025 年 12 月 1 日

CAR-T Immunotherapy Targeting CD19- ALL

计划入组 100 人 · 首次发布于 2019 年 7 月 11 日

Autologous TRICAR-ALL T-cells

In vivo CAR-T (Mustang)

anti-TdT/HLA-A*0201 CAR T-cell therapy (B-ALL/T-ALL)

Kumasi Centre For Collaborative Research In Tropical Medicine

Ghana

ARBOR RESEARCH COLLABORATIVE FOR HEALTH

United States

Foundation For A Smoke-Free World, Inc.

United States

Peak CAR T-Cell Expansion Linked to Improved Outcomes in B-ALL Patients Receiving Brexu-Cel

Real-World Evidence Reveals Disparities in CAR T-Cell Therapy Outcomes Across Patient Demographics

Real-World CAR-T Therapy Outcomes Show Promise Despite Higher Toxicity Rates in Diverse Patient Population